Drug Safety

, Volume 31, Issue 10, pp 885–885 | Cite as

Early Post-Marketing Pharmacovigilance of BLASTOFERON®: An Interferon Beta 1a Biosimilar

  • M. Kauffman
  • M. Papouchado
  • E. Gonzalez
  • A. Sterin-Prync
  • A. Vidal
  • R. Diez
  • H. Ferro
Abstract

Keywords

Sentinel Site Relapse Remit Pharmacovigilance Action Biosimilar Product Pharmacovigilance Program 

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • M. Kauffman
    • 1
  • M. Papouchado
    • 2
  • E. Gonzalez
    • 3
  • A. Sterin-Prync
    • 2
  • A. Vidal
    • 2
  • R. Diez
    • 1
  • H. Ferro
    • 1
  1. 1.Drug Safety Unit. Bio Sidus S.A.Argentina
  2. 2.Bio Sidus S.AArgentina
  3. 3.Centro de Diagnostico Molecular S.A.Argentina

Personalised recommendations